Want to see ACHC full AI Analyst Report?
Acadia Healthcare (ACHC) Ratios
Acadia Healthcare Ratios
ACHC's free cash flow for Q2 2026 was $238.63M. For the 2026 fiscal year, ACHC's free cash flow was increased by $76.56M and operating cash flow was $162.07M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 1.00 | 0.67 | 1.30 | 1.22 |
| Quick Ratio | 1.54 | 0.99 | 0.67 | 1.29 | 1.21 |
| Cash Ratio | 0.25 | 0.13 | 0.11 | 0.25 | 0.33 |
| Solvency Ratio | -0.27 | 0.15 | 0.04 | 0.19 | 0.14 |
| Operating Cash Flow Ratio | 0.25 | 0.22 | 0.52 | 0.98 | 0.92 |
| Short-Term Operating Cash Flow Coverage | 2.60 | 1.69 | 15.82 | 17.91 | 20.14 |
| Net Current Asset Value | $ -2.57B | $ -2.19B | $ -1.88B | $ -1.58B | $ -1.69B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.35 | 0.28 | 0.31 | 0.34 |
| Debt-to-Equity Ratio | 1.36 | 0.68 | 0.54 | 0.54 | 0.65 |
| Debt-to-Capital Ratio | 0.58 | 0.40 | 0.35 | 0.35 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.56 | 0.38 | 0.33 | 0.33 | 0.37 |
| Financial Leverage Ratio | 2.84 | 1.94 | 1.93 | 1.77 | 1.89 |
| Debt Service Coverage Ratio | -4.03 | 2.75 | 1.79 | 5.14 | 4.10 |
| Interest Coverage Ratio | 2.79 | 4.49 | 6.17 | 6.70 | 5.38 |
| Debt to Market Cap | 1.96 | 0.54 | 0.19 | 0.19 | 0.28 |
| Interest Debt Per Share | 30.80 | 24.03 | 17.51 | 17.83 | 19.32 |
| Net Debt to EBITDA | -3.42 | 3.31 | 7.46 | 2.55 | 3.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.61% | 22.57% | 23.31% | 96.16% | 96.08% |
| EBIT Margin | -27.98% | 14.53% | 1.94% | 17.01% | 15.24% |
| EBITDA Margin | -22.27% | 19.27% | 6.46% | 21.52% | 19.85% |
| Operating Profit Margin | 11.71% | 16.56% | 17.30% | 17.92% | 17.91% |
| Pretax Profit Margin | -32.18% | 10.84% | -0.87% | 14.33% | 11.91% |
| Net Profit Margin | -33.29% | 8.10% | -0.74% | 10.46% | 8.24% |
| Continuous Operations Profit Margin | -32.96% | 8.39% | -0.53% | 10.73% | 9.00% |
| Net Income Per EBT | 103.46% | 74.77% | 85.44% | 73.00% | 69.13% |
| EBT Per EBIT | -274.75% | 65.46% | -5.01% | 80.00% | 66.53% |
| Return on Assets (ROA) | -19.95% | 4.29% | -0.40% | 5.48% | 4.00% |
| Return on Equity (ROE) | -56.58% | 8.32% | -0.78% | 9.71% | 7.57% |
| Return on Capital Employed (ROCE) | 7.76% | 9.71% | 11.33% | 10.17% | 9.50% |
| Return on Invested Capital (ROIC) | 7.68% | 7.37% | 6.91% | 7.53% | 7.10% |
| Return on Tangible Assets | -26.67% | 7.06% | -0.71% | 10.16% | 7.63% |
| Earnings Yield | -85.68% | 7.04% | -0.31% | 3.70% | 3.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.08 | 7.47 | 6.82 | 7.38 | 7.60 |
| Payables Turnover | 18.15 | 10.49 | 14.39 | 0.96 | 0.92 |
| Inventory Turnover | 480.01 | 431.90 | 423.80 | 19.70 | 18.95 |
| Fixed Asset Turnover | 1.02 | 1.06 | 1.23 | 1.25 | 1.21 |
| Asset Turnover | 0.60 | 0.53 | 0.55 | 0.52 | 0.49 |
| Working Capital Turnover Ratio | 22.96 | -21.74 | -34.06 | 25.10 | 3.55 |
| Cash Conversion Cycle | 40.71 | 14.90 | 29.02 | -313.48 | -329.41 |
| Days of Sales Outstanding | 60.07 | 48.83 | 53.53 | 49.46 | 48.01 |
| Days of Inventory Outstanding | 0.76 | 0.85 | 0.86 | 18.53 | 19.26 |
| Days of Payables Outstanding | 20.11 | 34.78 | 25.37 | 381.48 | 396.68 |
| Operating Cycle | 60.83 | 49.68 | 54.39 | 67.99 | 67.27 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.45 | 1.42 | 5.08 | 4.24 | 4.22 |
| Free Cash Flow Per Share | -4.85 | -6.12 | 0.42 | 0.94 | 1.46 |
| Dividend Paid and CapEx Coverage Ratio | 0.23 | 0.19 | 1.09 | 1.29 | 1.53 |
| Capital Expenditure Coverage Ratio | 0.23 | 0.19 | 1.09 | 1.29 | 1.53 |
| Operating Cash Flow Coverage Ratio | 0.05 | 0.06 | 0.31 | 0.25 | 0.23 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.04 | 0.16 | 0.15 | 0.16 |
| Free Cash Flow Yield | -34.18% | -15.43% | 0.54% | 1.14% | 2.41% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.17 | 14.21 | -326.40 | 27.03 | 28.26 |
| Price-to-Sales (P/S) Ratio | 0.39 | 1.15 | 2.41 | 2.83 | 2.33 |
| Price-to-Book (P/B) Ratio | 0.66 | 1.18 | 2.54 | 2.62 | 2.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.93 | -6.48 | 185.10 | 87.45 | 41.56 |
| Price-to-Operating Cash Flow Ratio | 9.76 | 28.01 | 15.30 | 19.40 | 14.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.01 | 3.03 | 0.65 | -0.22 |
| Enterprise Value Multiple | -5.16 | 9.28 | 44.86 | 15.69 | 15.00 |
| Enterprise Value | 3.81B | 5.64B | 8.48B | 8.81B | 6.89B |
| EV to EBITDA | -5.16 | 9.28 | 44.86 | 15.69 | 15.00 |
| EV to Sales | 1.15 | 1.79 | 2.90 | 3.38 | 2.98 |
| EV to Free Cash Flow | -8.66 | -10.06 | 222.02 | 104.41 | 53.16 |
| EV to Operating Cash Flow | 28.88 | 43.50 | 18.35 | 23.16 | 18.41 |
| Tangible Book Value Per Share | 8.24 | 9.34 | 6.47 | 6.71 | 3.52 |
| Shareholders’ Equity Per Share | 21.49 | 33.55 | 30.59 | 31.36 | 28.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | 0.23 | 0.38 | 0.25 | 0.24 |
| Revenue Per Share | 36.52 | 34.42 | 32.20 | 29.11 | 26.07 |
| Net Income Per Share | -12.16 | 2.79 | -0.24 | 3.05 | 2.15 |
| Tax Burden | 1.03 | 0.75 | 0.85 | 0.73 | 0.69 |
| Interest Burden | 1.15 | 0.75 | -0.45 | 0.84 | 0.78 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.06 | 0.06 | 0.06 | 0.61 | 0.61 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Income Quality | -0.12 | 0.49 | -29.52 | 1.36 | 1.91 |
Currency in USD
